Evotec SE (EVO) Other Non Operating Income (2009 - 2025)
Evotec SE's (EVO) quarterly Other Non Operating Income came in at -$12.4 million in Q4 2025, down 233.72% year-over-year from $9.3 million in Q4 2024, and down 988.54% quarter-over-quarter from $1.4 million in Q3 2025.
Analysis
Evotec SE (EVO) Other Non Operating Income (2009 - 2025) Analysis & Trends
Evotec SE has disclosed Other Non Operating Income across 9 years of filings, most recently posting -$12.4 million for Q4 2025.
- In Q4 2025, Other Non Operating Income fell 233.72% year-over-year to -$12.4 million; the TTM figure through Dec 2025 stood at -$10.2 million (down 127.33% YoY), while the FY2025 annual figure was -$21.2 million, down 3180.54% from the prior year.
- Other Non Operating Income came in at -$12.4 million for Q4 2025 at Evotec SE, down from $1.4 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $9.3 million in Q4 2024 to a low of -$12.4 million in Q3 2024.
- Average Other Non Operating Income over 5 years is -$743596.8, with a median of $12062.4 recorded in 2021.
- Year-over-year, Other Non Operating Income jumped 30490.93% in 2021 and tumbled 4408552.42% in 2023.
- Over 5 years, Other Non Operating Income stood at $8.8 million in 2021, then plunged by 100.0% to $77.54 in 2022, then slumped by 4408552.42% to -$3.4 million in 2023, then soared by 370.88% to $9.3 million in 2024, then slumped by 233.72% to -$12.4 million in 2025.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$12.4 million in Q4 2025, $1.4 million in Q3 2025, and -$8.5 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -12.38 Mn |
| Sep 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | -8.50 Mn |
| Dec 31, 2024 | 9.26 Mn |
| Sep 30, 2024 | -12.40 Mn |
| Mar 31, 2024 | 2.06 Mn |
| Dec 31, 2023 | -3.42 Mn |
| Aug 29, 2023 | -587.85 |
| Jun 30, 2023 | -13,640.96 |
| Dec 31, 2022 | 77.54 |
| Sep 30, 2022 | 2.03 Mn |
| Jun 30, 2022 | 21,672.99 |
| Mar 31, 2022 | 402,919.24 |
| Dec 31, 2021 | 8.81 Mn |
| Sep 30, 2021 | 69,577.95 |
| Jun 30, 2021 | 12,042.71 |
| Mar 31, 2021 | 12,062.36 |
| Dec 31, 2020 | 814,293.43 |
| Sep 30, 2020 | -228.94 |
| Dec 31, 2019 | 52,023.72 |